Purpose of the Test
- Early prediction of preeclampsia development
- Short-term rule-out of preeclampsia onset
- Assisting doctors in clinical management decisions
Book Preeclampsia sFlt-1/PlGF Test | Lahalak Medical Platform
A precision diagnostic test that predicts the risk of preeclampsia before symptoms appear, enabling proactive medical intervention to ensure the safety and well-being of both mother and baby.
Scientific name: Serial sFlt-1/PlGF Ratio Monitoring
A laboratory test measuring two specific proteins to evaluate preeclampsia risk in high-risk pregnancies, assisting clinicians in making informed management decisions and ensuring maternal safety during prenatal care.
Service type
Laboratory test
Duration
15-20 minutes
Fasting
Fasting is not required
Included Services
- Blood sample collection
- sFlt-1 level analysis
- PlGF level analysis
- Results and ratio report
Medical Service Information
Target Groups
- Pregnant women with gestational hypertension
- Women with a history of preeclampsia
- Multiple pregnancies or diabetic patients
Importance of Serial Monitoring
- Accurate monitoring of ratio changes over time
- Early detection of placental dysfunction
- Ensuring fetal safety and reducing preterm births
Conditions & Notices
- Recommended for high-risk pregnancies
- Repeat testing as per physician recommendation
Medical services you might also like
